An 18-Year Dataset on the Clinical Incidence and MICs to Antibiotics of Achromobacter spp. (Labeled Biochemically or by MAL-DI-TOF MS as A. xylosoxidans), Largely in Patient Groups Other than Those with CF

Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry for Rapid Detection of Isolates Belonging to the Epidemic Clones Achromobacter xylosoxidans ST137 and Achromobacter ruhlandii DES from Cystic Fibrosis Patients

(2021) Thomas Garrigos et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Global Distribution Patterns of Carbapenemase-Encoding Bacteria in a New Light: Clues on a Role for Ethnicity

(2021) Claudio Neidhöfer et al.   Frontiers in Cellular and Infection Microbiology

Genomic characterization of Achromobacter species isolates from chronic and occasional lung infection in cystic fibrosis patients

(2021) Laura Veschetti et al.   Microbial Genomics

Detection and Characterization of Clinical Bordetella trematum Isolates from Chronic Wounds

(2021) Christian Buechler et al.   Pathogens

Achromobacter Infections and Treatment Options

(2020) Burcu Isler et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Faecal microbiota transplantation for eradicating carriage of multidrug-resistant organisms: a systematic review

(2019) S. Saha et al.   CLINICAL MICROBIOLOGY AND INFECTION

Study of 109 Achromobacter spp. isolates from 9 French CF centres reveals the circulation of a multiresistant clone of A. xylosoxidans belonging to ST 137

(2019) Lucie Amoureux et al.   Journal of Cystic Fibrosis

Evaluation of the immunochromatographic NG-test Carba5 for rapid identification of carbapenemase in non-fermenters

(2019) Anaïs Potron et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Gut Microbiota Modulation for Multidrug-Resistant Organism Decolonization: Present and Future Perspectives

(2019) Livia Gargiullo et al.   Frontiers in Microbiology

Mediastinitis superinfected by Achromobacter xylosoxidans. A case report

(2018) Karine Marion-Sanchez et al.   JOURNAL OF INFECTION AND CHEMOTHERAPY

Effect of respiratory Achromobacter spp. infection on pulmonary function in patients with cystic fibrosis

(2018) R. Recio et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Carbapenem-resistant Gram-negative pathogens in a German university medical center: Prevalence, clinical implications and the role of novel β-lactam/β-lactamase inhibitor combinations

(2018) Juri Katchanov et al.   PLoS One

Prevalence and Outcomes of Achromobacter Species Infections in Adults with Cystic Fibrosis: a North American Cohort Study

(2017) B. D. Edwards et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Prevalence and species distribution of Achromobacter sp. cultured from cystic fibrosis patients attending the Aarhus centre in Denmark

(2017) Sinne Søberg Gade et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Uncovering Differences in Virulence Markers Associated with Achromobacter Species of CF and Non-CF Origin

(2017) Brankica Filipic et al.   Frontiers in Cellular and Infection Microbiology

MALDI-TOF MS Versus VITEK®2: Comparison of Systems for the Identification of Microorganisms Responsible for Bacteremia

(2016) Filomena Febbraro et al.   CURRENT MICROBIOLOGY

Achromobacter xylosoxidans is the predominant Achromobacter species isolated from diverse non-respiratory samples

(2016) L. AMOUREUX et al.   EPIDEMIOLOGY AND INFECTION

Distribution of the species of Achromobacter in a French Cystic Fibrosis Centre and multilocus sequence typing analysis reveal the predominance of A. xylosoxidans and clonal relationships between some clinical and environmental isolates

(2016) Lucie Amoureux et al.   Journal of Cystic Fibrosis

Hospital Acquired Pneumonia Due to Achromobacter spp. in a Geriatric Ward in China: Clinical Characteristic, Genome Variability, Biofilm Production, Antibiotic Resistance and Integron in Isolated Strains

(2016) Chao Liu et al.   Frontiers in Microbiology

Fecal Microbiota Transplantation and Successful Resolution of Multidrug-Resistant-Organism Colonization

(2015) Nancy F. Crum-Cianflone et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Genomic Insights into Intrinsic and Acquired Drug Resistance Mechanisms in Achromobacter xylosoxidans

(2014) Yongfei Hu et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Detection of Achromobacter xylosoxidans in Hospital, Domestic, and Outdoor Environmental Samples and Comparison with Human Clinical Isolates

(2013) Lucie Amoureux et al.   APPLIED AND ENVIRONMENTAL MICROBIOLOGY

Bacteremia due to Achromobacter xylosoxidans in neonates: clinical features and outcome

(2013) Ozden Turel et al.   Brazilian Journal of Infectious Diseases

Genetic and Biochemical Characterization of a Novel Metallo-β-Lactamase, TMB-1, from an Achromobacter xylosoxidans Strain Isolated in Tripoli, Libya

(2012) Allaaeddin El Salabi et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Innate Aminoglycoside Resistance of Achromobacter xylosoxidans Is Due to AxyXY-OprZ, an RND-Type Multidrug Efflux Pump

(2012) Julien Bador et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Achromobacter xylosoxidans: An Emerging Pathogen Carrying Different Elements Involved in Horizontal Genetic Transfer

(2012) German Matías Traglia et al.   CURRENT MICROBIOLOGY

Evaluation of the Bruker Biotyper and Vitek MS Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry Systems for Identification of Nonfermenting Gram-Negative Bacilli Isolated from Cultures from Cystic Fibrosis Patients

(2012) Daniel C. Marko et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Epidemiology and resistance of Achromobacter xylosoxidans from cystic fibrosis patients in Dijon, Burgundy: First French data

(2012) Lucie Amoureux et al.   Journal of Cystic Fibrosis

First Description of an RND-Type Multidrug Efflux Pump in Achromobacter xylosoxidans, AxyABM

(2011) Julien Bador et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Achromobacter xylosoxidans respiratory tract infection in cystic fibrosis patients

(2011) A. Lambiase et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Marked increase in incidence of Achromobacter xylosoxidans infections caused by sporadic acquisition from the environment

(2011) Winnie Ridderberg et al.   Journal of Cystic Fibrosis

Two unique presentations of Achromobacter xylosoxidans infections in clinical settings

(2011) Vandana Kalwaje Eshwara et al.   Journal of Infection in Developing Countries

Bordetella holmesii Bacteremia in Asplenic Children: Report of Four Cases Initially Misidentified as Acinetobacter lwoffii

(2010) M. I. Panagopoulos et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Performance of Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Identification of Bacterial Strains Routinely Isolated in a Clinical Microbiology Laboratory

(2010) A. Bizzini et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Inflammation in Achromobacter xylosoxidans infected cystic fibrosis patients

(2009) C.R. Hansen et al.   Journal of Cystic Fibrosis

Urinary tract infection due toAchromobacter xylosoxidans: Report of 9 cases

(2008) Daniel Tena et al.   SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES